News
🇪🇺 EMALatest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 1–12 of 355 articles
Quick answer
NovaPharmaNews Europe & United Kingdom news feed tracks 355 published stories — EMA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
Duty of care at oncology conferences spotlights planetary health research
Synthetic real-world data reshapes oncology trial decision-making
EMA approved 104 human medicines in 2025: what changed
EMA Post Authorisation Guidance Faces Evidence Gaps After 10 Years
EMA approves TX01 PIP, unlocking the PUMA pathway for Theranexus and Exeltis
CHMP backs nerandomilast for IPF and PPF in EU
KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026)
EU secures emergency Favipiravir deliveries for hantavirus response
Eye drugs list: Sodium hyaluronate, tafluprost, tobramycin uses
World Lightproof Bottle Opaque Liners Market: Pharma Growth to 2035
EMEA 2026 Life Sciences Report: Key Market Shifts for Pharma BD and Investors
Maersk Europe Market Update June 2026: Key Changes for Pharma Supply Chains
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.